» Articles » PMID: 33529230

High-level Expression of the Monomeric SARS-CoV-2 S Protein RBD 320-537 in Stably Transfected CHO Cells by the EEF1A1-based Plasmid Vector

Overview
Journal PLoS One
Date 2021 Feb 2
PMID 33529230
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The spike (S) protein is one of the three proteins forming the coronaviruses' viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a highly specific minimal antigen for serological tests. Correct exposure of antigenic determinants has a significant impact on the accuracy of such tests-the antigen has to be correctly folded, contain no potentially antigenic non-vertebrate glycans, and, preferably, should have a glycosylation pattern similar to the native S protein. Based on the previously developed p1.1 vector, containing the regulatory sequences of the Eukaryotic translation elongation factor 1 alpha gene (EEF1A1) from Chinese hamster, we created two expression constructs encoding SARS-CoV-2 RBD with C-terminal c-myc and polyhistidine tags. RBDv1 contained a native viral signal peptide, RBDv2 -human tPA signal peptide. We transfected a CHO DG44 cell line, selected stably transfected cells, and performed a few rounds of methotrexate-driven amplification of the genetic cassette in the genome. For the RBDv2 variant, a high-yield clonal producer cell line was obtained. We developed a simple purification scheme that consistently yielded up to 30 mg of RBD protein per liter of the simple shake flask cell culture. Purified proteins were analyzed by polyacrylamide gel electrophoresis in reducing and non-reducing conditions and gel filtration; for RBDv2 protein, the monomeric form content exceeded 90% for several series. Deglycosylation with PNGase F and mass spectrometry confirmed the presence of N-glycosylation. The antigen produced by the described technique is suitable for serological tests and subunit vaccine studies.

Citing Articles

Expression of Recombinant Tissue Plasminogen Activator - Plasminogen Activator Inhibitor Complex in Mammal Cells as Quality Control Materials in Immunoassay.

Yang Y, Zhang Z, Luo H, Chen C, Liu T, Lin G Protein J. 2025; .

PMID: 40042554 DOI: 10.1007/s10930-025-10257-w.


Leveraging Walnut Somatic Embryos as a Biomanufacturing Platform for Recombinant Proteins and Metabolites.

Zaini P, Haddad K, Feinberg N, Ophir Y, Nandi S, McDonald K BioTech (Basel). 2024; 13(4).

PMID: 39584907 PMC: 11586998. DOI: 10.3390/biotech13040050.


Expression and purification of the receptor-binding domain of SARS-CoV-2 spike protein in mammalian cells for immunological assays.

Abraham E, Bajusz C, Marton A, Borics A, Mdluli T, Pardi N FEBS Open Bio. 2023; 14(3):380-389.

PMID: 38129177 PMC: 10909970. DOI: 10.1002/2211-5463.13754.


Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens.

Boggiano-Ayo T, Palacios-Oliva J, Lozada-Chang S, Relova-Hernandez E, Gomez-Perez J, Oliva G Front Bioeng Biotechnol. 2023; 11:1287551.

PMID: 38050488 PMC: 10693982. DOI: 10.3389/fbioe.2023.1287551.


Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein.

Green E, Hamaker N, Lee K BMC Biotechnol. 2023; 23(1):7.

PMID: 36882740 PMC: 9990576. DOI: 10.1186/s12896-023-00777-7.


References
1.
Du L, Zhao G, Chan C, Li L, He Y, Zhou Y . A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity. Viral Immunol. 2010; 23(2):211-9. PMC: 2883479. DOI: 10.1089/vim.2009.0090. View

2.
de Assis R, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero J . Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nat Commun. 2021; 12(1):6. PMC: 7782488. DOI: 10.1038/s41467-020-20095-2. View

3.
. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells. Sci Rep. 2020; 10(1):21779. PMC: 7732851. DOI: 10.1038/s41598-020-78711-6. View

4.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M . A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020; 26(7):1033-1036. PMC: 8183627. DOI: 10.1038/s41591-020-0913-5. View

5.
Chen W, Du L, Chag S, Ma C, Tricoche N, Tao X . Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum Vaccin Immunother. 2013; 10(3):648-58. PMC: 4130269. DOI: 10.4161/hv.27464. View